Unknown

Dataset Information

0

Glatiramer acetate-induced acute hepatotoxicity in an adolescent with MS.


ABSTRACT: Glatiramer acetate (GA), a synthetic copolymer, is a frequently used first-line treatment for relapsing-remitting multiple sclerosis (RRMS). Probable autoimmune hepatotoxicity during GA treatment has been reported,(1-4) but GA hepatotoxicity in the absence of positive autoimmune markers has not previously been described. Here, we report GA-induced hepatotoxicity in a pediatric patient with multiple sclerosis (MS).

SUBMITTER: Makhani N 

PROVIDER: S-EPMC3908464 | biostudies-literature | 2013 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Glatiramer acetate-induced acute hepatotoxicity in an adolescent with MS.

Makhani Naila N   Ngan Bo-yee BY   Kamath Binita M BM   Yeh E Ann EA  

Neurology 20130724 9


Glatiramer acetate (GA), a synthetic copolymer, is a frequently used first-line treatment for relapsing-remitting multiple sclerosis (RRMS). Probable autoimmune hepatotoxicity during GA treatment has been reported,(1-4) but GA hepatotoxicity in the absence of positive autoimmune markers has not previously been described. Here, we report GA-induced hepatotoxicity in a pediatric patient with multiple sclerosis (MS). ...[more]

Similar Datasets

| S-EPMC4828679 | biostudies-literature
| S-EPMC3557359 | biostudies-literature
| S-EPMC9298260 | biostudies-literature
| S-EPMC4064013 | biostudies-literature
| S-EPMC6372117 | biostudies-literature
| S-EPMC3705142 | biostudies-literature
| S-EPMC9954767 | biostudies-literature
| S-EPMC6276114 | biostudies-literature
| S-EPMC5079236 | biostudies-literature
| S-EPMC5608765 | biostudies-literature